Welcome to our dedicated page for Somnigroup International SEC filings (Ticker: SGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Somnigroup International Inc. filings document regulatory disclosures for a NYSE-listed bedding company with common stock trading under SGI. Form 8-K reports cover operating and financial results, financial guidance, quarterly cash dividends, Regulation FD investor presentations, and other material-event disclosures tied to its omnichannel bedding platform.
Proxy materials describe board and shareholder voting matters, executive compensation, equity awards and governance practices. Company disclosures also identify business segments such as Mattress Firm, Tempur Sealy North America and Tempur Sealy International, along with capital-structure information for its common stock.
Somnigroup International Inc. confirmed that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on June 3, 2026 in connection with its previously announced Agreement and Plan of Merger with Leggett & Platt, Incorporated, dated April 13, 2026. Somnigroup states it expects the transaction to close by year-end 2026, subject to conditions including Leggett & Platt shareholder adoption of the Merger Agreement, required competition clearances in Canada, the EU, the UK and the Republic of Korea, applicable foreign investment clearances in Austria, effectiveness of a Form S-4 registration statement, and the absence of any material adverse effect with respect to either company.
Somnigroup International Inc. confirmed that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on June 3, 2026 in connection with its previously announced Agreement and Plan of Merger with Leggett & Platt, Incorporated, dated April 13, 2026. Somnigroup states it expects the transaction to close by year-end 2026, subject to conditions including Leggett & Platt shareholder adoption of the Merger Agreement, required competition clearances in Canada, the EU, the UK and the Republic of Korea, applicable foreign investment clearances in Austria, effectiveness of a Form S-4 registration statement, and the absence of any material adverse effect with respect to either company.
Somnigroup International Inc. reports a key step toward its planned acquisition of Leggett & Platt. The mandatory 30-day waiting period under the U.S. Hart-Scott-Rodino antitrust law expired on June 3, 2026, removing one regulatory hurdle. Somnigroup still needs Leggett & Platt shareholder approval, additional competition and foreign investment clearances in several jurisdictions, effectiveness of a Form S-4 registration statement, and no material adverse changes at either company. Somnigroup currently expects the merger to close by year-end 2026, but highlights numerous risks and uncertainties that could delay or prevent completion.
SOMNIGROUP INTERNATIONAL INC. insider Steven H. Rusing, President & CEO Mattress Firm, reported a mix of option exercises and share sales in Common Stock. On May 22, 2026, he exercised stock options to acquire 10,448 shares at an exercise price of $15.6100 per share, converting a derivative award into directly held stock.
That same day he sold a total of 6,657 shares in open-market transactions at reported prices of $67.4850 and $66.7927 per share, with a footnote noting a weighted average price and a range from $66.4850 to $67.10. After these transactions, he holds 299,660 shares of Common Stock directly and 22,400 shares indirectly through a family limited liability company. A footnote explains the exercised option was adjusted for a 4-for-1 stock split that occurred on November 24, 2020.
NEU RICHARD W reported acquisition or exercise transactions in this Form 4 filing.
Somnigroup International Inc. director Richard W. Neu reported an award of 2,657 restricted stock units tied to the company’s common stock. Each unit represents the right to receive one share of common stock, and the units vest in full on the first anniversary of the grant date. Following this equity award, Neu directly holds 173,812 shares of Somnigroup common stock.
Madden Meredith Siegfried reported acquisition or exercise transactions in this Form 4 filing.
SomniGroup International Inc. director Meredith Siegfried Madden received a grant of 2,657 restricted stock units on May 13, 2026, at no cash cost. Each unit represents one share of common stock and vests in full on the first anniversary of the grant date, bringing her direct holdings to 17,780 shares.
Gates Cathy R. reported acquisition or exercise transactions in this Form 4 filing.
Somnigroup International Inc. director Cathy R. Gates received an equity award of 2,657 restricted stock units, each representing one share of common stock. The grant was made at no cash cost to her. These restricted stock units vest in full on the first anniversary of the grant date.
Following this award, Gates directly holds 41,232 shares of Somnigroup common stock. This filing reflects routine stock-based compensation rather than an open-market purchase or sale.
Dilsaver Evelyn S reported acquisition or exercise transactions in this Form 4 filing.
SOMNIGROUP INTERNATIONAL INC. director Evelyn S. Dilsaver received a grant of 2,657 restricted stock units, representing the right to receive an equal number of common shares. The award was recorded at a price of $0.00 per share as a compensation grant, not an open-market purchase.
The restricted stock units vest in full on the first anniversary of the grant date. After this award, Dilsaver’s direct ownership increased to 156,574 shares of common stock, showing this as a relatively small, routine addition to her existing stake.
SOMNIGROUP INTERNATIONAL INC. director Christopher Thomas Cook received a grant of 2,657 shares of common stock in the form of restricted stock units. These units vest in full on the first anniversary of the grant date and will then convert into shares. Following this equity award, Cook holds 124,110 shares directly.
Somnigroup International Inc. director Peter R. Sachse reported an acquisition of 2,657 shares of common stock through a grant of restricted stock units. Each restricted stock unit represents the right to receive one share of common stock and vests in full on the first anniversary of the grant date. Following this grant, Sachse directly holds 65,947 shares of Somnigroup common stock.